Neurochemical Effects of Methylenedioxymethamphetamine in the Rat: Acute Versus Long-Term Changes

作者: Christopher J. Schmidt , Vicki L. Taylor

DOI: 10.1007/978-1-4613-1485-1_9

关键词: StimulantAmphetamineMDMANeurotoxicityMedicineMethamphetamineNeuroscienceDopaminergicNeurochemicalSerotonergic

摘要: Amphetamine-like central stimulants are one of the most well-studied classes pharmacological agents known today. This is due to fact that their behavioral activity believed be mediated primarily by monoamines, which themselves have been scrutinized sufficiently earned title “classical transmitters.” In spite attention given this class and relatively well-described neurochemical activities, there remains a great deal about these drugs we do not understand. The neurotoxicity associated with high doses many unexplained actions. Although term dose used, it important point out often in range humans exposed. particularly true case 3,4-methylenedioxymethamphetamine (MDMA), as has described elsewhere book. amphetamines selective, affects neuronal systems through mediate effects, i.e., monoaminergic systems. Thus amphetamine, cause majority its stimulant activities dopamine release, causes persistent damage selectively dopaminergic processes [1]. Methamphetamine, also potent releaser 5-HT, neurotoxic both serotonergic [2]. Finally, selective p-chloroamphetamine (PCA) correlates 5-HT release presumed basis most, though all, behavior effects [3].

参考文章(26)
G R Hanson, J W Gibb, J K Ritter, C J Schmidt, P K Sonsalla, Role of dopamine in the neurotoxic effects of methamphetamine. Journal of Pharmacology and Experimental Therapeutics. ,vol. 233, pp. 539- 544 ,(1985)
E Sanders-Bush, L R Steranka, Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism. Journal of Pharmacology and Experimental Therapeutics. ,vol. 206, pp. 460- 467 ,(1978)
C J Schmidt, Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics. ,vol. 240, pp. 1- 7 ,(1987)
Ray W. Fuller, Kenneth W. Perry, Bryan B. Molloy, Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine. European Journal of Pharmacology. ,vol. 33, pp. 119- 124 ,(1975) , 10.1016/0014-2999(75)90145-4
Michel Johnson, Donna M. Stone, Glen R. Hanson, James W. Gibb, Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system European Journal of Pharmacology. ,vol. 135, pp. 231- 234 ,(1987) , 10.1016/0014-2999(87)90616-9
Elaine Sanders-Bush, Larry R. Steranka, IMMEDIATE AND LONG-TERM EFFECTS OF p-CHLOROAMPHETAMINE ON BRAIN AMINES Annals of the New York Academy of Sciences. ,vol. 305, pp. 208- 221 ,(1978) , 10.1111/J.1749-6632.1978.TB31525.X
A.D. Sherman, W.-C. Hsiao, E.M. Gál, Cerebral metabolism of (3H)-p-chloroamphetamine. Neuropharmacology. ,vol. 16, pp. 17- 24 ,(1977) , 10.1016/0028-3908(77)90041-7
J. W. Gibb, F. J. Kogan, Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 310, pp. 185- 187 ,(1979) , 10.1007/BF00500283